Comparing the current results to its competitors, Volitionrx Limited reported Revenue decrease in the 2 quarter 2026 year on year by -1.97 %, despite the revenue increase by the most of its competitors of 14.31 %, recorded in the same quarter.
Volitionrx Limited's Comment on Competition and Industry Peers
The company operates in a competitive environment alongside healthcare, pharmaceutical, and diagnostic firms including Exact Sciences Corporation, Guardant Health, GRAIL Inc., Natera, Caris Life Sciences, Freenome Holdings Inc., CellMax Life, Archer DX Inc., Foundation Medicine Inc., Oncocyte Corporation, OpKo Health Inc., MDNA Life Sciences Inc., Abbott Laboratories Inc., Cepheid Inc., Hologic Corporation, Agilent Technologies Inc., Qiagen Inc., Thermo Fisher, Illumina, Becton Dickinson, BioMerieux, Siemens, Gen-Probe Incorporated, EpiGenomics AG, MDxHealth SA, Roche Diagnostics, Cytovale Inc., and Immunexpress Inc. In the veterinary sector, One Health Company (Fidocure) is also a competitor. Many of these competitors possess greater financial and technical resources, larger marketing, sales, and distribution networks, broader product portfolios beyond diagnostic testing, and stronger brand recognition. Technological advancements by competitors may potentially render the company’s technologies and products obsolete prior to market entry or revenue generation. The company’s future performance depends on timely product development, maintaining technological relevance, achieving market acceptance, and establishing name recognition and a positive reputation within healthcare.
Cardio Diagnostics Holdings Inc is a medical diagnostics company that specializes in cardiovascular health. Their business model focuses on developing and commercializing innovative diagnostic solutions for detecting and monitoring heart-related conditions. By leveraging advanced technologies and partnerships, they aim to provide healthcare professionals with accurate and timely information to enhance their patients' cardiovascular care.
Guardant Health Inc's business model revolves around providing advanced genomic testing services for cancer patients. It specializes in developing liquid biopsy tests that analyze circulating tumor DNA (ctDNA) in the blood. These tests help in early cancer detection, treatment selection, and monitoring of cancer progression. Guardant Health Inc collaborates with healthcare providers, pharmaceutical companies, and researchers to provide these innovative tests and contribute to the advancement of precision medicine in oncology.
Hologic Incs business model focuses on developing and commercializing medical technologies and diagnostic products, primarily dedicated to womens healthcare. Their offerings include innovative solutions for breast and skeletal health, gynecological health, and surgical products, aiming to improve patient outcomes and enhance healthcare practices.
Illumina Inc is a leading company in the genomics sector, focusing on next-generation sequencing technologies that enhance genetic analysis. Their business model encompasses a diverse range of products, including sequencing platforms, reagents, and bioinformatics solutions, which together facilitate comprehensive genomic studies for researchers. By integrating these tools, Illumina supports advancements in fields such as oncology, drug discovery, and personalized healthcare, positioning itself at the forefront of genomic innovation.
Sources:
Volitionrx Limited’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Volitionrx Limited versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
